Showing results (291-300 of 346) with videos related to
Sort By:
Pageof 35
Journal of Neurosurgery|December 1, 1988
Prognostic implications of the proliferative potential of low-grade astrocytomasT Hoshino, L A Rodriguez, K G Cho, et al.Journal of Neuro-Oncology|January 1, 1994
Proliferative potential and prognostic evaluation of low-grade astrocytomasS Ito, K L Chandler, M D Prados, et al.Journal of Neuropathology and Experimental Neurology|November 24, 1998
Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumorsW D Brown, F H Gilles, C J Tavaré, et al.Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 4, 2000
Definitive classes of childhood supratentorial neuroglial tumors. The Childhood Brain Tumor ConsortiumF H Gilles, A Leviton, C J Tavaré, et al.Cancer|March 16, 2000
Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor ConsortiumF H Gilles, W D Brown, A Leviton, et al.Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Protein-membrane interactions: blood clotting on nanoscale bilayersJ H Morrissey, V Pureza, R L Davis-Harrison, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 1, 1990
Stability of brain intracellular lactate and 31P-metabolite levels at reduced intracellular pH during prolonged hypercapnia in ratsY Cohen, L H Chang, L Litt, et al.International Journal of Radiation Oncology, Biology, Physics|April 1, 1991
Low-dose craniospinal radiation therapy for medulloblastomaF E Halberg, W M Wara, L F Fippin, et al.The Journal of School Health|October 1, 1985
Selecting and recruiting health programs for the School Health Education EvaluationS L Owen, M A Kirkpatrick, S W Lavery, et al.Cancer Treatment Reports|November 1, 1986
Phase II study of combined carmustine, 5-fluorouracil, hydroxyurea, and 6-mercaptopurine (BFHM) for the treatment of malignant gliomasV A Levin, S Phuphanich, H C Liu, et al.Pageof 35